炎症性肠病患者对新型冠状病毒（SARS-CoV-2）的血清学反应减弱，且可能影响免疫接种。
Serological response to SARS-CoV-2 is attenuated in patients with inflammatory bowel disease and can affect immunization.
作者信息
Ghavami Shaghayegh Baradaran, Shahrokh Shabnam, Asadzadeh Aghdaei Hamid, Khoramjoo Seyed Mobin, Farmani Maryam, Kazemifard Nesa, Parigi Tommaso Lorenzo, Danese Silivio, Balaii Hedieh, Sherkat Ghazal, Ebrahimi Daryani Nasser, Alborzi Foroogh, Vossoughinia Hassan, Zali Mohammad Reza
机构信息
Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases Shahid Beheshti University of Medical Sciences Tehran Iran.
Department of Biomedical Sciences Humanitas University Milan Italy.
出版信息
JGH Open. 2022 Mar 17;6(4):266-269. doi: 10.1002/jgh3.12725. eCollection 2022 Apr.
In this study we indicated that impaired serological responses to SARS-CoV-2 infection among patients with IBD, could have significant implications for this group of patients and should be considered in vaccination program.
在本研究中，我们指出，炎症性肠病患者对SARS-CoV-2感染的血清学反应受损，可能对这组患者有重大影响，在疫苗接种计划中应予以考虑。
Zotero 插件